ArticleFrontiers in pharmacology2019

Inhibition of mPGES-1 or COX-2 Results in Different Proteomic and Lipidomic Profiles in A549 Lung Cancer Cells.

Filip Bergqvist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.